Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary uterine angiosarcoma.

L E Mendez1, S Joy, R Angioli

  • 1University of Miami School of Medicine/Jackson Memorial Hospital, Miami, Florida 33136, USA.

Gynecologic Oncology
|October 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women.

European review for medical and pharmacological sciences·2024
Same author

The role of peritoneal lavage in benign gynecologic laparoscopic surgery.

European review for medical and pharmacological sciences·2023
Same author

Nocardia farcinica ventriculitis and meningitis in an immunocompromised man with Crohn's disease.

Infectious diseases now·2021
Same author

Hemorrhagic cystitis in pregnancy: Case report and review of the literature.

Journal of neonatal-perinatal medicine·2017
Same author

Reply: "Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-years follow-up".

Medical oncology (Northwood, London, England)·2016
Same author

Inflammasome-dependent IL-1β release depends upon membrane permeabilisation.

Cell death and differentiation·2016
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

This study presents a rare case of primary uterine angiosarcoma in a Hispanic American woman. Uterine angiosarcomas are aggressive tumors with poor prognosis, highlighting the need for better treatment strategies.

Area of Science:

  • Gynecologic Oncology
  • Vascular Neoplasms
  • Pathology

Background:

  • Primary uterine angiosarcoma is a rare and aggressive malignancy.
  • Literature review of uterine angiosarcomas to identify common presentations and outcomes.

Observation:

  • A case of primary uterine angiosarcoma in a Hispanic American woman is reported.
  • Seventy-four percent of 19 reviewed cases were perimenopausal women with a mean age of 55.
  • Common symptoms include pelvic mass, menorrhagia, and weight loss.

Findings:

  • Uterine angiosarcomas exhibit highly malignant behavior with a poor prognosis.
  • Tumor size and extrapelvic disease are key prognostic factors.
  • Survival at 12 months was 43% for evaluable patients, with recurrence at 8.2 months.

Related Experiment Videos

Implications:

  • Early diagnosis and aggressive management are crucial for improving outcomes.
  • Further research is needed to establish optimal treatment protocols for uterine angiosarcoma.
  • This case contributes to the limited understanding of uterine angiosarcoma in diverse populations.